Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Drug Resistance

  Free Subscription


Articles published in Infect Control Hosp Epidemiol

Retrieve available abstracts of 88 articles:
HTML format



Single Articles


    March 2024
  1. WANG L, Zeng C, Li X, Li Y, et al
    Mortality associated with carbapenem resistance in Klebsiella pneumoniae bloodstream infection: A propensity score-matched study.
    Infect Control Hosp Epidemiol. 2024 Mar 15:1-8. doi: 10.1017/ice.2024.
    PubMed     Abstract available


  2. ABIMANSOUR J, Martin JA, Petersen BT
    Implementation of multidrug-resistant bacterial testing to prioritize duodenoscope sterilization: Experience from a high-volume health system.
    Infect Control Hosp Epidemiol. 2024;45:397-399.
    PubMed    


    February 2024
  3. CUI J, Heavey J, Lin L, Klein EY, et al
    Modeling relaxed policies for discontinuation of methicillin-resistant Staphylococcus aureus contact precautions.
    Infect Control Hosp Epidemiol. 2024 Feb 26:1-6. doi: 10.1017/ice.2024.
    PubMed     Abstract available


  4. FONTANA L, Hakki M, Ozer EA, Laird A, et al
    The impact of an intervention to reduce dispersal from wastewater drain sites on carbapenem-resistant Pseudomonas aeruginosa colonization and bloodstream infection on a hematopoietic cell transplant and hematologic malignancy unit.
    Infect Control Hosp Epidemiol. 2024 Feb 22:1-9. doi: 10.1017/ice.2023.
    PubMed     Abstract available


    January 2024
  5. KISS CR, Ryan S, Meyer J, Kotsanas D, et al
    Impact of change in vancomycin-resistant Enterococcus infection prevention policy.
    Infect Control Hosp Epidemiol. 2024 Jan 22:1-2. doi: 10.1017/ice.2023.
    PubMed    


  6. WARREN BG, Smith BA, Barrett A, Graves AM, et al
    Identification of carbapenem-resistant organism (CRO) contamination of in-room sinks in intensive care units in a new hospital bed tower.
    Infect Control Hosp Epidemiol. 2024 Jan 19:1-8. doi: 10.1017/ice.2023.
    PubMed     Abstract available


  7. ADEDIRAN TY, Robinson GL, Johnson JK, Liang Y, et al
    Factors associated with patient-to-healthcare personnel (HCP) and HCP-to-subsequent patient transmission of methicillin-resistant Staphylococcus aureus.
    Infect Control Hosp Epidemiol. 2024 Jan 18:1-7. doi: 10.1017/ice.2023.
    PubMed     Abstract available


    December 2023
  8. SIMON SJ, Sater M, Herriott I, Huntley M, et al
    Staphylococcus epidermidis joint isolates: Whole-genome sequencing demonstrates evidence of hospital transmission and common antimicrobial resistance.
    Infect Control Hosp Epidemiol. 2023 Dec 15:1-7. doi: 10.1017/ice.2023.
    PubMed     Abstract available


  9. HUYNH DN, Shah PJ, Greenlee SB, Long SW, et al
    Evaluation of computerized clinical decision support system to reduce unnecessary nasal methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) testing.
    Infect Control Hosp Epidemiol. 2023 Dec 12:1-3. doi: 10.1017/ice.2023.
    PubMed     Abstract available


    September 2023
  10. BEN-DAVID D, Cohen Y, Levi G, Keren-Paz A, et al
    Contribution of active surveillance cultures to the control of hospital-acquired carbapenem-resistant Acinetobacter baumannii in an endemic hospital setting.
    Infect Control Hosp Epidemiol. 2023 Sep 20:1-8. doi: 10.1017/ice.2023.
    PubMed     Abstract available


  11. PETTIT NN, Nguyen CT, Lew AK, Pisano J, et al
    Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (SAAR) data for anti
    Infect Control Hosp Epidemiol. 2023 Sep 13:1-5. doi: 10.1017/ice.2023.
    PubMed     Abstract available


    August 2023
  12. BOPP TC, Marchesi M, Zihlmann R, Sax H, et al
    Identifying patients at high risk for multidrug-resistant organisms after hospitalization abroad.
    Infect Control Hosp Epidemiol. 2023;44:1281-1288.
    PubMed     Abstract available


    July 2023
  13. ROTHBERG MB, Haessler S, Deshpande A, Yu PC, et al
    Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia.
    Infect Control Hosp Epidemiol. 2023;44:1143-1150.
    PubMed     Abstract available


    June 2023
  14. POPOVICH KJ, Aureden K, Ham DC, Harris AD, et al
    SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update.
    Infect Control Hosp Epidemiol. 2023 Jun 29:1-29. doi: 10.1017/ice.2023.
    PubMed     Abstract available


  15. FARTHING TS, Jolley A, Nickel KB, Hill C, et al
    Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patients.
    Infect Control Hosp Epidemiol. 2023 Jun 29:1-6. doi: 10.1017/ice.2023.
    PubMed     Abstract available


    May 2023
  16. DATTA R, Pirruccio G, Fried TR, O'Leary JR, et al
    Antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae urine isolates from a national sample of home-based primary care patients with dementia.
    Infect Control Hosp Epidemiol. 2023 May 22:1-4. doi: 10.1017/ice.2023.
    PubMed     Abstract available


    April 2023
  17. YIN LJ, He LY, Lu GP, Cao Y, et al
    Active screening and patient-placement and cohort-placement strategies to decrease carbapenem-resistant gram-negative bacilli colonization and infection in pediatric patients: A 5-year retrospective observational study in China.
    Infect Control Hosp Epidemiol. 2023 Apr 24:1-4. doi: 10.1017/ice.2023.
    PubMed     Abstract available


  18. ASSENHOLM KRISTENSEN M, Skov Abrantes J, Jensen HI, Backer Mogensen C, et al
    The association between socioeconomic factors and the success of decolonization treatment among individuals diagnosed with methicillin-resistant Staphylococcus aureus: A cohort study from 2007 to 2020.
    Infect Control Hosp Epidemiol. 2023 Apr 5:1-9. doi: 10.1017/ice.2023.
    PubMed     Abstract available


    March 2023
  19. SCHECHNER V, Lerner AO, Temkin E, Carmeli Y, et al
    Carbapenem-resistant Acinetobacter baumannii load in patients and their environment: the importance of detecting carriers.
    Infect Control Hosp Epidemiol. 2023 Mar 27:1-3. doi: 10.1017/ice.2023.
    PubMed     Abstract available


  20. ARORA HS, Khan H, Ailumerab H, Natarajan G, et al
    A tale of two intensive care units (ICUs): Baseline Staphylococcus aureus colonization and mupirocin susceptibility in neonatal and pediatric patients requiring intensive care.
    Infect Control Hosp Epidemiol. 2023;44:447-452.
    PubMed     Abstract available


    February 2023
  21. DABAJA-YOUNIS HK, Schechner V, Firan I, Khamaysi I, et al
    Identification and control of two outbreaks of unrelated New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli traced to the same endoscope defect.
    Infect Control Hosp Epidemiol. 2023 Feb 23:1-3. doi: 10.1017/ice.2023.
    PubMed     Abstract available


  22. ATKINSON A, Ellenberger B, Piezzi V, Kaspar T, et al
    Extending outbreak investigation with machine learning and graph theory: Benefits of new tools with application to a nosocomial outbreak of a multidrug-resistant organism.
    Infect Control Hosp Epidemiol. 2023;44:246-252.
    PubMed     Abstract available


    January 2023
  23. MATSUI M, Katayama Y
    Effect of nasal mupirocin treatment on extranasal carriage of methicillin-resistant Staphylococcus aureus among pediatric patients admitted to the neonatal intensive care unit.
    Infect Control Hosp Epidemiol. 2023 Jan 11:1-3. doi: 10.1017/ice.2022.
    PubMed     Abstract available


    December 2022
  24. SCHWABER MJ, Temkin E, Lobl R, Schechner V, et al
    Hospital-acquired bacterial infections in coronavirus disease 2019 (COVID-19) patients in Israel.
    Infect Control Hosp Epidemiol. 2022 Dec 23:1-6. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  25. SMITH MW, Carrel M, Goto M
    County-level spatiotemporal distribution of fluoroquinolone-resistant Enterobacteriaceae in outpatient settings of the Veterans' Health Administration, 2000-2017.
    Infect Control Hosp Epidemiol. 2022 Dec 2:1-3. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  26. LEVINSON KJ, Collins ME, Lachiewicz AM, Koltun AJ, et al
    Retrospective analysis of multidrug-resistant clinical and environmental isolates for the presence of the colistin-resistance gene mcr-1.
    Infect Control Hosp Epidemiol. 2022;43:1957-1960.
    PubMed    


    November 2022
  27. LEE ALH, Leung ECM, Wong BWH, Wong LCH, et al
    Clean clothes or dirty clothes? Outbreak investigation of carbapenem-resistant Acinetobacter baumannii related to laundry contamination through multilocus sequence typing (MLST).
    Infect Control Hosp Epidemiol. 2022 Nov 8:1-7. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  28. DE AGUIAR AC, Perlin Silva JF, Kim LM, Rosot RK, et al
    Investigation of multidrug-resistant bacteria in dogs enrolled at animal-assisted therapy in a trauma and surgical emergency hospital.
    Infect Control Hosp Epidemiol. 2022;43:1722-1723.
    PubMed    


    October 2022
  29. PFISTER TR, Chow B, Shen Y, Ellison J, et al
    The associated impact of standardized admission screening on vancomycin-resistant Enterococci bloodstream infections.
    Infect Control Hosp Epidemiol. 2022 Oct 6:1-5. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  30. CHAONONGHIN S, Jantarathaneewat K, Weber DJ, Warren DK, et al
    Impact of antibiotic heterogeneity by periodic antibiotic monitoring and supervision strategy at two units with different prevalences of multidrug-resistant organisms.
    Infect Control Hosp Epidemiol. 2022;43:1501-1504.
    PubMed     Abstract available


    September 2022
  31. ADEDIRAN TY, Hitchcock S, Johnson JK, Stine OC, et al
    Molecular concordance of methicillin-resistant Staphylococcus aureus isolates from healthcare workers and patients.
    Infect Control Hosp Epidemiol. 2022 Sep 30:1-11. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  32. ASLAM S, Asrat H, Liang R, Qiu W, et al
    Methicillin-Resistant Staphylococcus aureus Bacteremia during the COVID-19 Pandemic: Trends and Distinguishing Characteristics among Patients in a Health Care System in New York City.
    Infect Control Hosp Epidemiol. 2022 Sep 9:1-12. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  33. KELLY BJ, Bekele S, Loughrey S, Huang E, et al
    Healthcare microenvironments define multidrug-resistant organism persistence.
    Infect Control Hosp Epidemiol. 2022;43:1135-1141.
    PubMed     Abstract available


    August 2022
  34. SPERLING CD, Rose L, Yang H, Byrne DD, et al
    Evaluation of Escherichia coli resistance to fluoroquinolones in men undergoing prostate procedures: Is it time to change preoperative prophylaxis?
    Infect Control Hosp Epidemiol. 2022;43:1078-1080.
    PubMed    


  35. GONTJES KJ, Gibson KE, Lansing B, Cassone M, et al
    Can alternative anatomical sites and environmental surveillance replace perianal screening for multidrug-resistant organisms in nursing homes?
    Infect Control Hosp Epidemiol. 2022;43:1063-1066.
    PubMed     Abstract available


    July 2022
  36. ZHANG HL, Gontjes KJ, Han JH, Alby K, et al
    Characterization of resistance to newer antimicrobials among carbapenem-resistant Klebsiella pneumoniae in the post-acute-care setting.
    Infect Control Hosp Epidemiol. 2022 Jul 28:1-4. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  37. TAMMA PD, Bergman Y, Jacobs EB, Lee JH, et al
    Comparing the activity of novel antibiotic agents against carbapenem-resistant Enterobacterales clinical isolates.
    Infect Control Hosp Epidemiol. 2022 Jul 13:1-6. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  38. IDIGO AJ, Brown ML, Wiener HW, Griffin RL, et al
    How fluoroquinolone preauthorization affects third- and fourth-generation cephalosporin use and resistance in a large academic hospital.
    Infect Control Hosp Epidemiol. 2022;43:848-859.
    PubMed     Abstract available


    June 2022
  39. NAKASHIMA T, Inoue H, Sakemi Y, Yamashita H, et al
    Effectiveness of umbilical culture for surveillance of methicillin-resistant Staphylococcus aureus among neonates admitted to neonatal intensive care units.
    Infect Control Hosp Epidemiol. 2022 Jun 30:1-3. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  40. SCHAPS D, Dever R, Parente VM, Anderson DJ, et al
    Methicillin-resistant Staphylococcus aureus nasal colonization in children with cerebral palsy.
    Infect Control Hosp Epidemiol. 2022 Jun 23:1-3. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  41. QUAN KA, Sater MRA, Uy C, Clifton-Koeppel R, et al
    Epidemiology and genomics of a slow outbreak of methicillin-resistant Staphyloccus aureus (MRSA) in a neonatal intensive care unit: Successful chronic decolonization of MRSA-positive healthcare personnel.
    Infect Control Hosp Epidemiol. 2022 Jun 16:1-8. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  42. WERTH BJ, Dilworth TJ, Escobar ZK, Gross AE, et al
    Reporting behaviors and perceptions toward the National Healthcare Safety Network antimicrobial use (AU) and antimicrobial resistance (AR) modules.
    Infect Control Hosp Epidemiol. 2022 Jun 15:1-7. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  43. ROTTIER WC, Pinholt M, van der Bij AK, Arpi M, et al
    Attributable mortality of vancomycin resistance in ampicillin-resistant Enterococcus faecium bacteremia in Denmark and the Netherlands: A matched cohort study.
    Infect Control Hosp Epidemiol. 2022;43:719-727.
    PubMed     Abstract available


    May 2022
  44. ONG SWX, Rao P, Khong WX, Ong VYF, et al
    Genomic surveillance uncovers ongoing transmission of carbapenem-resistant Acinetobacter baumannii (CRAB) and identifies actionable routes of transmissions in an endemic setting.
    Infect Control Hosp Epidemiol. 2022 May 23:1-7. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  45. KON H, Temkin E, Elmalih P, Keren-Paz A, et al
    Analysis of four carbapenem-resistant Acinetobacter baumannii outbreaks using Fourier-transform infrared spectroscopy.
    Infect Control Hosp Epidemiol. 2022 May 10:1-3. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  46. GIBSON KE, Mills JP, Mantey JA, Lansing BJ, et al
    Multidrug-resistant organism (MDRO) contamination of privacy curtains in nursing homes.
    Infect Control Hosp Epidemiol. 2022;43:666-668.
    PubMed    


    April 2022
  47. ELLINGSON KD, Noble BN, Buser GL, Snyder GM, et al
    Interfacility transfer communication of multidrug-resistant organism colonization or infection status: Practices and barriers in the acute-care setting.
    Infect Control Hosp Epidemiol. 2022;43:448-453.
    PubMed     Abstract available


  48. DE ANDRADE AP, Arend LNVS, Ribeiro VST, Tuon FF, et al
    Resistance of clinical and environmental Acinetobacter baumannii against quaternary ammonium.
    Infect Control Hosp Epidemiol. 2022;43:527-530.
    PubMed    


    March 2022
  49. HTUN HL, Hon PY, Tan R, Ang B, et al
    Synergistic effects of length of stay and prior MDRO carriage on the colonization and co-colonization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and carbapenemase-producing Enterobacterales across healthcare set
    Infect Control Hosp Epidemiol. 2022 Mar 30:1-9. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  50. MADERA S, McNeil N, Serpa PH, Kamm J, et al
    Prolonged silent carriage, genomic virulence potential and transmission between staff and patients characterize a neonatal intensive care unit (NICU) outbreak of methicillin-resistant Staphylococcus aureus (MRSA).
    Infect Control Hosp Epidemiol. 2022 Mar 21:1-7. doi: 10.1017/ice.2022.
    PubMed     Abstract available


  51. KLEINMAN DR, Mitchell R, McCracken M, Hota SS, et al
    Vancomycin-resistant Enterococcus sequence type 1478 spread across hospitals participating in the Canadian Nosocomial Infection Surveillance Program from 2013 to 2018.
    Infect Control Hosp Epidemiol. 2022 Mar 10:1-7. doi: 10.1017/ice.2022.
    PubMed     Abstract available


    February 2022
  52. OLIVEIRA JDS, Sampaio NCFM, Leite GS, Pereira MADM, et al
    Acquisition of carbapenem-resistant gram-negative bacilli among intensive care unit (ICU) patients with no previous use of carbapenems: Indirect population impact of antimicrobial use.
    Infect Control Hosp Epidemiol. 2022 Feb 14:1-5. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  53. PARK SY, Lee JS, Oh J, Lee SH, et al
    Effectiveness of selective digestive decolonization therapy using oral gentamicin for eradication of carbapenem-resistant Enterobacteriaceae carriage.
    Infect Control Hosp Epidemiol. 2022 Feb 9:1-6. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  54. HOWARD-ANDERSON JR, Earley M, Komarow L, Abbo L, et al
    Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales.
    Infect Control Hosp Epidemiol. 2022 Feb 2:1-7. doi: 10.1017/ice.2022.
    PubMed     Abstract available


    January 2022
  55. SCHECHNER V, Lellouche J, Stepansky S, Mandel D, et al
    Carriage of vancomycin-resistant Enterococcus faecium in infants following an outbreak in the neonatal intensive care unit: time to clearance of carriage and use of molecular methods to detect colonization.
    Infect Control Hosp Epidemiol. 2022 Jan 31:1-4. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  56. CHOI H, Chatterjee P, Hwang M, Stock EM, et al
    Can multidrug-resistant organisms become resistant to ultraviolet (UV) light following serial exposures? Characterization of post-UV genomic changes using whole-genome sequencing.
    Infect Control Hosp Epidemiol. 2022;43:72-78.
    PubMed     Abstract available


    December 2021
  57. HARRISON C, Zent R, Schneck E, Flynn CE, et al
    Infection prevention versus antimicrobial stewardship: Does nasal povidone-iodine interfere with methicillin-resistant Staphylococcus aureus (MRSA) screening?
    Infect Control Hosp Epidemiol. 2021 Dec 22:1-2. doi: 10.1017/ice.2021.
    PubMed    


  58. GUSSIN GM, Heim L, Tjoa T, McKinnell JA, et al
    Post-discharge decolonization of patients harboring methicillin-resistant Staphylococcus aureus (MRSA) USA300 strains: secondary analysis of the CLEAR Trial.
    Infect Control Hosp Epidemiol. 2021 Dec 16:1-4. doi: 10.1017/ice.2021.
    PubMed     Abstract available


    November 2021
  59. SUDA KJ, Traversa A, Patel U, Poggensee L, et al
    Uptake in newly approved antibiotics prescribed to patients with carbapenem-resistant Enterobacterales (CRE).
    Infect Control Hosp Epidemiol. 2021 Nov 24:1-4. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  60. NII DM, Martins MAV, Fortaleza CMCB
    Trends in antimicrobial susceptibility patterns in healthcare-associated methicillin-resistant Staphylococcus aureus from bloodstream infections: A joinpoint regression analysis.
    Infect Control Hosp Epidemiol. 2021 Nov 2:1-3. doi: 10.1017/ice.2021.
    PubMed    


  61. KENGKLA K, Wongsalap Y, Chaomuang N, Suthipinijtham P, et al
    Clinical and economic outcomes attributable to carbapenem-resistant Enterobacterales and delayed appropriate antibiotic therapy in hospitalized patients.
    Infect Control Hosp Epidemiol. 2021 Nov 2:1-11. doi: 10.1017/ice.2021.
    PubMed     Abstract available


    October 2021
  62. LIN G, Tseng KK, Gatalo O, Martinez DA, et al
    Cost-effectiveness of carbapenem-resistant Enterobacteriaceae (CRE) surveillance in Maryland.
    Infect Control Hosp Epidemiol. 2021 Oct 22:1-9. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  63. ALHMIDI H, Cadnum JL, Wilson BM, Donskey CJ, et al
    Transfer of methicillin-resistant Staphylococcus aureus by fist bump versus elbow bump.
    Infect Control Hosp Epidemiol. 2021 Oct 18:1-3. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  64. SERRA-BURRIEL M, Campillo-Artero C, Agodi A, Barchitta M, et al
    Association between antibiotic resistance in intensive care unit (ICU)-acquired infections and excess resource utilization: Evidence from Spain, Italy, and Portugal.
    Infect Control Hosp Epidemiol. 2021 Oct 18:1-8. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  65. MITSUBOSHI S, Yamaguchi T, Seino H, Fukuhara M, et al
    Regional outbreak of methicillin-resistant Staphylococcus aureus ST2725-t1784 in rural Japan.
    Infect Control Hosp Epidemiol. 2021;42:1294-1296.
    PubMed    


    August 2021
  66. WOLFENSBERGER A, Mang N, Gibson KE, Gontjes K, et al
    Understanding short-term transmission dynamics of methicillin-resistant Staphylococcus aureus in the patient room.
    Infect Control Hosp Epidemiol. 2021 Aug 27:1-8. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  67. HEIM LT, Miller LG, Singh RD, McKinnell JA, et al
    Double-swab 5% versus single-swab 10% iodophor for reducing methicillin-resistant Staphylococcus aureus with routine chlorhexidine bathing.
    Infect Control Hosp Epidemiol. 2021 Aug 26:1-3. doi: 10.1017/ice.2021.
    PubMed     Abstract available


    July 2021
  68. SCHAPS D, Godfrey AW, Anderson DJ
    Risk of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) acquisition during ambulance transport: A retrospective propensity-score-matched cohort analysis.
    Infect Control Hosp Epidemiol. 2021 Jul 21:1-6. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  69. AUNG AH, Kyaw WM, Heng YK, Tey HL, et al
    Intranasal octenidine for methicillin-resistant Staphylococcus aureus (MRSA) carriers and universal octenidine bathing reduced MRSA acquisition in an acute-care general ward.
    Infect Control Hosp Epidemiol. 2021 Jul 16:1-4. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  70. KHAWCHAROENPORN T, Kanoktipakorn P
    Effectiveness of appropriate antibiotic prophylaxis for transurethral resection of the prostate in the era of antibiotic resistance.
    Infect Control Hosp Epidemiol. 2021 Jul 15:1-5. doi: 10.1017/ice.2021.
    PubMed     Abstract available


    June 2021
  71. APISARNTHANARAK A, Weber DJ
    Strategy to Limit Multi-Drug Resistant Acinetobacter baumannii Transmission in Cohort COVID-19 Critical Care Unit.
    Infect Control Hosp Epidemiol. 2021 Jun 24:1-5. doi: 10.1017/ice.2021.
    PubMed    


  72. RYNKIEWICH KR, Makhija J, Froilan MCM, Benson EC, et al
    Healthcare personnel experiences implementing carbapenem-resistant Enterobacterales infection control measures at a ventilator-capable skilled nursing facility-A qualitative analysis.
    Infect Control Hosp Epidemiol. 2021 Jun 21:1-7. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  73. SLOTT JENSEN ML, Chen M, Detlefsen M, Kudsk Klitgaard J, et al
    Whole-genome sequence analyses by a new easy-to-use software solution support the suspicion of a neonatal ward outbreak of methicillin-resistant Staphylococcus aureus (MRSA) and transmission between hospitals.
    Infect Control Hosp Epidemiol. 2021 Jun 9:1-3. doi: 10.1017/ice.2021.
    PubMed    


  74. TANWAR SSS, Weiner-Lastinger LM, Bell JM, Allen-Bridson K, et al
    Laboratory-identified vancomycin-resistant enterococci bacteremia incidence: A standardized infection ratio prediction model.
    Infect Control Hosp Epidemiol. 2021 Jun 4:1-5. doi: 10.1017/ice.2021.
    PubMed     Abstract available


    May 2021
  75. HELLMAN MD, Davis KW, Hackworth B, Evans ME, et al
    Implementing a postdischarge methicillin-resistant Staphylococcus aureus decolonization protocol within a Veterans Affairs Health Care System facility.
    Infect Control Hosp Epidemiol. 2021 May 24:1-2. doi: 10.1017/ice.2021.
    PubMed    


  76. CHO SY, Kim HM, Chung DR, Choi JR, et al
    The impact of vancomycin-resistant Enterococcus (VRE) screening policy change on the incidence of healthcare-associated VRE bacteremia.
    Infect Control Hosp Epidemiol. 2021 May 17:1-6. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  77. RIVERA F, Reeme A, Graham MB, Buchan BW, et al
    Surveillance cultures following a regional outbreak of carbapenem-resistant Acinetobacter baumannii.
    Infect Control Hosp Epidemiol. 2021 May 14:1-7. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  78. SHERRY NL, Lee RS, Gorrie CL, Kwong JC, et al
    Pilot study of a combined genomic and epidemiologic surveillance program for hospital-acquired multidrug-resistant pathogens across multiple hospital networks in Australia.
    Infect Control Hosp Epidemiol. 2021;42:573-581.
    PubMed     Abstract available


    April 2021
  79. WEILAND AS, Lu JY, Chen CS, Tjoa T, et al
    Impact of empiric antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) infection and associated Clostridioides difficile infection (CDI) risk: Secondary analysis of the CLEAR trial.
    Infect Control Hosp Epidemiol. 2021 Apr 16:1-4. doi: 10.1017/ice.2020.1412.
    PubMed     Abstract available


  80. PASCALE R, Bussini L, Gaibani P, Bovo F, et al
    Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: multicenter before-after cross sectional study.
    Infect Control Hosp Epidemiol. 2021 Apr 16:1-25. doi: 10.1017/ice.2021.
    PubMed     Abstract available


  81. RAUSEO AM, Hink T, Reske KA, Seiler SM, et al
    A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization.
    Infect Control Hosp Epidemiol. 2021 Apr 6:1-7. doi: 10.1017/ice.2021.
    PubMed     Abstract available


    March 2021
  82. FITZPATRICK MA, Suda KJ, Poggensee L, Vivo A, et al
    Epidemiology and clinical outcomes associated with extensively drug-resistant (XDR) Acinetobacter in US Veterans' Affairs (VA) medical centers.
    Infect Control Hosp Epidemiol. 2021;42:305-310.
    PubMed     Abstract available


    February 2021
  83. VO QT, Klevens RM, Bolstorff B, Barton K, et al
    Utilization of cumulative antibiograms for public health surveillance: Trends in Escherichia coli and Klebsiella pneumoniae susceptibility, Massachusetts, 2008-2018.
    Infect Control Hosp Epidemiol. 2021;42:169-175.
    PubMed     Abstract available


    January 2021
  84. ARTEAGA-LIVIAS K, Pinzas-Acosta K, Perez-Abad L, Panduro-Correa V, et al
    A Multidrug Resistant Klebsiella pneumoniae outbreak in a Peruvian hospital. Another threat from the COVID-19 pandemic.
    Infect Control Hosp Epidemiol. 2021 Jan 5:1-6. doi: 10.1017/ice.2020.1401.
    PubMed    


    December 2020
  85. BORK JT, Leekha S, Claeys K, Seung H, et al
    Change in Hospital Antibiotic Use and Acquisition of Multidrug Resistant Gram-Negative Organisms After the Onset of Coronavirus Disease 2019.
    Infect Control Hosp Epidemiol. 2020 Dec 10:1-13. doi: 10.1017/ice.2020.1360.
    PubMed     Abstract available


    August 2020
  86. PUNJABI C, Madaline T, Gendlina I, Chen V, et al
    Prevalence of MRSA in Respiratory cultures and Diagnostic Performance of the MRSA Nasal PCR In Patients hospitalized with COVID-19 Pneumonia.
    Infect Control Hosp Epidemiol. 2020 Aug 26:1-8. doi: 10.1017/ice.2020.
    PubMed    


    April 2020
  87. RUTALA WA, Gergen MF, Sickbert-Bennett EE, Weber DJ, et al
    Comparative evaluation of the microbicidal activity of low-temperature sterilization technologies to steam sterilization.
    Infect Control Hosp Epidemiol. 2020;41:391-395.
    PubMed     Abstract available


  88. TESHOME BF, Vouri SM, Hampton NB, Kollef MH, et al
    Evaluation of a ceiling effect on the association of new resistance development to antipseudomonal beta-lactam exposure in the critically ill.
    Infect Control Hosp Epidemiol. 2020;41:484-485.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.